Article
Impact of the <i>MDM2</i> SNP309 and <i>p53</i> Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
28 Oct 2005
Abstract excerpt
Li-Fraumeni syndrome, resulting from p53 (TP53) germline mutations, represents one of the most devastating genetic predispositions to cancer. Recently, the MDM2 SNP309 (T-->G variation) was shown to be associated with accelerated tumour formation in p53 mutation carriers. The impact of the common p53 codon 72 polymorphism on cancer risk remains controversial. We therefore investigated the effect of these two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
